Core Viewpoint - Zhejiang Dongfang's stock price has shown significant fluctuations, with a year-to-date increase of 37.40% but a recent decline over the past five trading days by 9.50% [1] Group 1: Stock Performance - As of November 24, Zhejiang Dongfang's stock price rose by 2.11% to 6.29 CNY per share, with a trading volume of 299 million CNY and a turnover rate of 1.41%, resulting in a total market capitalization of 21.483 billion CNY [1] - The stock has experienced a net inflow of 6.3267 million CNY from main funds, with large orders accounting for 23.12% of purchases and 21.81% of sales [1] - The company has appeared on the trading leaderboard seven times this year, with the most recent instance on February 14, where it recorded a net buy of -28.9574 million CNY [1] Group 2: Company Overview - Zhejiang Dongfang Financial Holding Group Co., Ltd. was established on October 26, 1994, and listed on December 1, 1997, with its main business activities including trade circulation, real estate, garment production, and various financial services [2] - The revenue composition for the company includes futures business at 80.29%, financing leasing at 7.81%, insurance at 5.07%, trust business at 3.32%, and other investments at 0.64% [2] - As of September 30, the number of shareholders decreased by 13.26% to 157,700, while the average circulating shares per person increased by 15.29% to 21,661 shares [2] Group 3: Financial Performance - For the period from January to September 2025, Zhejiang Dongfang reported operating revenue of 5.988 billion CNY, a year-on-year decrease of 39.66%, while the net profit attributable to shareholders increased by 91.22% to 800 million CNY [2] - The company has distributed a total of 2.287 billion CNY in dividends since its A-share listing, with 745 million CNY distributed over the past three years [3] Group 4: Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited is the fifth-largest circulating shareholder, holding 21.045 million shares, an increase of 408,400 shares from the previous period [3] - Southern CSI 1000 ETF, ranked seventh among circulating shareholders, reduced its holdings by 182,700 shares to 18.746 million shares [3]

Market Overview - The diversified financial sector experienced a decline of 3.29% on November 21, with Ruida Futures leading the drop [1] - The Shanghai Composite Index closed at 3834.89, down 2.45%, while the Shenzhen Component Index closed at 12538.07, down 3.41% [1] Stock Performance - Key stocks in the diversified financial sector showed varied performance, with Jiangsu Jinzu remaining unchanged at 6.45, while Ruida Futures fell by 6.28% to 21.05 [2] - Other notable declines included Yalian Development down 6.18% and Jiuding Investment down 5.99% [2] Trading Volume and Capital Flow - The total net outflow of main funds in the diversified financial sector was 870 million yuan, while retail investors saw a net inflow of 756 million yuan [2] - The trading volume for Jiangsu Jinzu was 335,600 shares, with a transaction amount of 216 million yuan, while Ruida Futures had a trading volume of 149,100 shares and a transaction amount of 320 million yuan [2][3] Individual Stock Capital Flow - Bohai Leasing had a net inflow of 11.66 million yuan from main funds, while Jiangsu Jinzu saw a net inflow of 3.58 million yuan [3] - Conversely, stocks like Yalian Development and Jiuding Investment experienced significant net outflows from main funds, amounting to 6.68 million yuan and 7.94 million yuan respectively [3]

Market Overview - The diversified financial sector experienced a decline of 0.22% on November 17, with the electric power investment sector leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers in the diversified financial sector included: - *ST Rendo (002647): Closed at 7.66, up 3.65% with a trading volume of 207,700 shares and a turnover of 157 million [1] - Zhejiang Dongfang (600120): Closed at 6.95, up 2.36% with a trading volume of 1,106,100 shares and a turnover of 766 million [1] - Haide Co. (000567): Closed at 8.00, up 2.04% with a trading volume of 479,300 shares and a turnover of 379 million [1] - Major decliners included: - Electric Power Investment (000958): Closed at 7.08, down 3.01% with a trading volume of 1,942,200 shares and a turnover of 1.404 billion [2] - Xiangman Rongtong (600830): Closed at 10.14, down 2.22% with a trading volume of 108,100 shares and a turnover of 110 million [2] Capital Flow - The diversified financial sector saw a net outflow of 298 million from institutional investors, while retail investors experienced a net inflow of 200 million [2] - Specific stock capital flows included: - Zhejiang Dongfang (600120): Institutional net outflow of 48.03 million, retail net inflow of 80.69 million [3] - *ST Rendo (002647): Institutional net inflow of 16.53 million, retail net outflow of 8.36 million [3] - Electric Power Investment (000958): Significant institutional net outflow of 14.04 billion [2]

浙江东方金融控股集团股份有限公司 浙江东方金融控股集团股份有限公司（600120） 2025 年第二次临时股东会会议资料 浙江东方金融控股集团股份有限公司 2025 年第二次临时股东会 会议资料 股权登记日：2025 年 11 月 18 日 会议召开日：2025 年 11 月 25 日 1 / 12 浙江东方金融控股集团股份有限公司（600120） 2025 年第二次临时股东会会议资料 2025 年第二次临时股东会现场会议议程 会议时间：2025 年 11 月 25 日 14：30 会议地点：浙江省杭州市上城区西湖大道 12 号新东方大厦 18 楼大会议室 主 持 人：董事长王正甲先生 一、主持人宣布会议正式开始 宣布本次现场到会股东人数、代表股份数，董事及列席人员情 况 二、发言人介绍本次会议各项议案 | 序号 | 议案内容 | | 发言人 | | --- | --- | --- | --- | | 1 | 关于续聘公司 2025 年度审计机构的议案 | 何 | 欣 | | 2 | 关于公司 2025 年中期利润分配预案 | 何 | 欣 | | 3 | 关于关联方向公司控股子公司提供借款额度的议案 | 何 ...

Group 1 - The company will hold its second extraordinary general meeting of shareholders on November 25, 2025, to discuss additional proposals [1][3] - Zhejiang International Trade Group Co., Ltd., the controlling shareholder, proposed to add a temporary proposal regarding the loan limit to the company's subsidiary [2][19] - The proposal has been approved by the independent directors and the board of directors, and it complies with relevant laws and regulations [2][19] Group 2 - The loan amount proposed is 1.3 billion yuan, intended for daily operations and debt replacement, with a validity period until July 20, 2026 [13][19] - The loan interest rate will not exceed 3.15% and will be subject to the weighted average interest rate of bank loans at the time of borrowing [13][19] - The board meeting on November 13, 2025, approved the proposal with a unanimous vote, excluding the related director from voting [42][43] Group 3 - The company is also establishing the "Oriental Zheyao Zhongying Binjiang Medical Fund" with a target size of 500 million yuan, involving several partners [21][22] - The fund will focus on supporting the biopharmaceutical and medical device industries, with a management fee of 0.75% per year during the investment period [31][38] - The fund's investment strategy includes a cap on single investments and a focus on mid to late-stage projects [33][38]

Core Points - Zhejiang Dongfang announced a board meeting on November 13, 2025, to approve a loan limit for its subsidiary, Guojin Leasing, from its controlling shareholder, Zhejiang International Trade Group [2] - The loan amount is set at 1.3 billion yuan, intended for daily operations and debt replacement, with a validity period until July 20, 2026 [2] - The loan can be reused within the validity period, with an interest rate not exceeding 3.15% and not higher than the weighted average bank borrowing rate at the time of borrowing [2] - The loan term will not exceed three years, and the transaction is classified as a related party transaction, pending shareholder approval [2]

Core Viewpoint - Zhejiang Dongfang (600120.SH) announced the establishment of the Dongfang Zheyao Fund, with a total fundraising target of 500 million yuan [1] Group 1: Fund Structure - The fund will be managed by Dongfang Chanrong, a wholly-owned subsidiary of Zhejiang Dongfang, in collaboration with Bank of China Asset Management, High-tech Jin Investment, and Zhejiang Pharmaceutical Group [1] - Dongfang Chanrong will act as the controlling shareholder, while Zhejiang Pharmaceutical Group's wholly-owned subsidiary, Hanting Capital, will co-establish a new pharmaceutical fund management company [1] Group 2: Investment Contributions - Bank of China Asset Management's wholly-owned subsidiary, Bank of China Capital Private Fund Management (Beijing) Co., Ltd. will serve as the second general partner (GP2) [1] - The investment contributions from limited partners include: - Chanrong Huiying: 119.2 million yuan (23.84%) - Zhejiang Pharmaceutical Group: 29.8 million yuan (5.96%) - Bank of China Asset Management: 149 million yuan (29.8%) - High-tech Jin Investment's subsidiary, Hangzhou High-tech (Rights Protection) Venture Capital Co., Ltd.: 200 million yuan (40%) [1]

Core Viewpoint - Zhejiang Dongfang (600120.SH) announced the establishment of the Dongfang Zheyao Fund, with a total fundraising target of 500 million yuan, aimed at investing in the pharmaceutical sector [1] Group 1: Fund Structure - Dongfang Chanyun, a wholly-owned subsidiary of Zhejiang Dongfang, will act as the fund manager [1] - The fund will be jointly established with partners including Bank of China Asset Management, High-tech Jin Investment, and Zhejiang Pharmaceutical Group [1] - The fund management company will be a joint venture between Dongfang Chanyun and a wholly-owned subsidiary of Zhejiang Pharmaceutical Group, Hanting Capital [1] Group 2: Capital Contributions - The total fundraising scale is set at 500 million yuan, with various partners contributing different amounts [1] - Limited partners include: - Chanyun Huiying: 119.2 million yuan (23.84%) - Zhejiang Pharmaceutical Group: 29.8 million yuan (5.96%) - Bank of China Asset Management: 149 million yuan (29.8%) - High-tech Jin Investment's subsidiary, Hangzhou High-tech Venture Capital: 200 million yuan (40%) [1]

Core Viewpoint - Zhejiang Dongfang announced the establishment of the "Dongfang Zhe Pharmaceutical Zhongying Binjiang Medical Fund" through a subsidiary, indicating a strategic move to enhance its investment portfolio and engage in related transactions [1] Company Summary - The company's revenue composition for the year 2024 is as follows: futures business accounts for 82.69%, financing leasing for 5.48%, other businesses for 4.21%, insurance for 4.07%, and trust business for 3.31% [1] - As of the report, Zhejiang Dongfang has a market capitalization of 23.7 billion yuan [1]

| 股票代码：600120 | 证券简称：浙江东方 | | | 编号：2025-062 | | --- | --- | --- | --- | --- | | 债券代码：138898.SH | 债券简称：23 | 东方 | 01 | | | 债券代码：240620.SH | 债券简称：24 | 东方 | 01 | | | 债券代码：241264.SH | 债券简称：24 | 东方 | K1 | | | 债券代码：241781.SH | 债券简称：24 | 东方 | 03 | | 浙江东方金融控股集团股份有限公司 关于关联方向公司控股子公司提供借款额度暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要事项提示： ● 本次关联交易系浙江东方金融控股集团股份有限公司（以下简称"公司"） 控股股东浙江省国际贸易集团有限公司（以下简称"省国贸集团"）向公司控股 子公司浙江国金融资租赁股份有限公司（以下简称"国金租赁"）提供借款额度 13 亿元，用于日常经营及债务置换，额度有效期至 2026 年 7 月 20 日，有效 ...